Nets 2016 IPO Was Overpriced Though Analysts Calls Were Closer
(Bloomberg Gadfly) -- It's official. One of the biggest IPOs of 2016 was mispriced.
A bunch of analysts think shares in Nets A/S aren't worth the selling price in September's initial public offering. Some of these number-crunchers happen to be employed by the banks that did the deal.
Nets shares have never closed above their 150 Danish kroner issue price and were 126.5 kroner on Thursday. Analysts at Deutsche Bank AG and Morgan Stanley, two of the three banks that ran the deal, still have price targets of 150 kroner and 160 kroner for the Danish payments processor.
But their peers at Nordea Bank AB, the third bank in charge of the offering, have a price target of 140 kroner. Analysts at Danske Bank A/S, JPMorgan Chase & Co. and UBS Group AG -- firms with a lesser role on the deal -- are at 130 or 140 kroner a share.
The analysts' research was available to prospective investors. Some of it would not have contained price targets back then, though Danske gave a 110 to 140 kroner price range.
These equity analysts are required to operate independently of the corporate finance divisions which handle IPOs and collect the fees. They are now being seen to be independent too. Despite that, their views didn't much influence Nets' IPO price, which was set by supply and demand in a short investor roadshow.
The price-setting process worked by investors saying how much stock they wanted and what they were willing to pay. There were enough orders at 150 kroner a share to buy the issue several times over. The current share price suggests this so-called book build didn't get to the right valuation, and the analysts were closer to the mark.Â
Nets seems to have attracted demand in quantity more than quality. Many of those that clamored for the stock were evidently short-term investors with no staying power. When it was clear Nets was not going to hold above its issue price, they dumped their holdings.
Not all IPOs go like this. Perhaps Nets' sheer size was unhelpful. This was Europe's third-largest deal this year, with $2.4 billion of stock being sold, and the company has suffered from some recent worries about mobile payments in the Nordic region.
It's a reminder to banks selling IPOs that quality, not quantity, of demand is what counts. IPOs will always suck in short-term money and if many buyers are in it for a quick turn, the shares will suffer. More cautious investors may want to skip the IPO, let the stock settle in the market and buy at a later date. And read the research.
This column does not necessarily reflect the opinion of Bloomberg LP and its owners.
To contact the author of this story: Chris Hughes in London at chughes89@bloomberg.net.
To contact the editor responsible for this story: Jennifer Ryan at jryan13@bloomberg.net.
-
Navigating Friction And Energy Realities: An Analysis Of Marco Rubio's October Visit To India
Occurring at a critical juncture marked by stalled trade negotiations and escalating geopolitical pressures over global energy supplies, the visit offers a profound window into modern US-India relations.
-
India Exports Capital. Why Not Export Trusteeship?
The big question, then, is whether India can build an institution that global borrowers, investors, banks, and lawyers can trust, even without an Indian connection.
-
France's Economy & Politics Are In Crisis | The Reason Why
Let's look at how the French economy and politics evolved under Nicolas Sarkozy, Franois Hollande and Emmanuel Macron.
-
You May Inherit The Business. You Must Earn Its Credibility.
Succession tests the founder's ability to share authority as much as it tests the next generation's readiness to assume it.
-
Signing Deals Is One Thing; Making Them Work Is Another | The Week In Whys
Sometimes, things don't turn out as planned. Indian companies have lost some bids to rivals, some projects won't produce until 2030.
-
FOMC Wall, PERM Suspension, Hospital Stocks | Talking Points This Week
A PERM suspension would directly affect green-card sponsorship rather than H-1B visas, so the near-term earnings impact could remain relatively limited. The key question is whether this marks a new phase in US scrutiny of Indian IT.
-
Everything, Everywhere, All At Once: Dalal Street's Week To Forget | Joining The Dots
Visa curbs, a Starlink spat and cancer drug caps: what connects this week's shocks for Indian markets
-
India Is Going Abroad For Critical Minerals. But It May Take Years To Pay Off | The Reason Why
Although India's steps are in the right direction, they remain modest compared with India's growing dependence.
-
When Everyone Has AI, What Gives You An Edge?
India's young workforce is entering an uncertain world of work where powerful AI tools are becoming widely accessible. The advantage will belong to those who combine deep expertise with digital fluency, and the distinctly human capabilities that technology cannot manufacture.
-
Wrong Labels, High Pesticide Residues Holding Back Agri Exports | The Reason Why
India needs stronger domestic food-safety and labelling standards, with best practices becoming part of everyday business for farmers, traders and food companies.